ADVERTISEMENT

Home|Journals|Articles by Year|Audio Abstracts
 

Original Article



DARS2 to distinguish squamous cell carcinoma from keratoacanthoma Investigation of biomarker properties

Ozlem Ucer ,Nevin Kocaman.




Abstract
Cited by 0 Articles

Objective: In this study, in the differential diagnosis of squamous cell carcinoma (CHC) and keratoacanthoma (CA)
It was aimed to investigate the efficiency of DARS2 protein expression.
Methods: A total of 60 cases, consisting of 30 SCC and 30 CA, diagnosed in Fırat University Faculty of Medicine, Department of Pathology, were examined immunohistochemically by studying the DARS2 protein.
Results: DARS2 expression values were found to be statistically significant in the differential diagnosis of SCC and CA (p

Key words: Squamous cell carcinoma, keratoacanthoma, immunohistochemistry, DARS2.





publications
0
supporting
0
mentioning
0
contrasting
0
Smart Citations
0
0
0
0
Citing PublicationsSupportingMentioningContrasting
View Citations

See how this article has been cited at scite.ai

scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.

6
9
6
9
9
14
13
15
24
17
23
15
29
8
2024-032024-042024-052024-062024-072024-082024-092024-102024-112024-122025-012025-022025-032025-04

Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Author Tools
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.


We use cookies and other tracking technologies to work properly, to analyze our website traffic, and to understand where our visitors are coming from. More Info Got It!